Filing Details
- Accession Number:
- 0001179110-18-004691
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-03-20 17:02:21
- Reporting Period:
- 2018-03-16
- Accepted Time:
- 2018-03-20 17:02:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1651308 | Beigene Ltd. | BGNE | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1663427 | Howard Liang | C/O Mourant Ozannes Corporate Services 94 Solaris Avenue Camana Bay, Grand Cayman E9 KY1-1108 | Cfo & Chief Strategy Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| American Depositary Shares | Acquisiton | 2018-03-16 | 10,872 | $6.50 | 15,872 | No | 4 | M | Direct | |
| American Depositary Shares | Disposition | 2018-03-16 | 1,000 | $154.95 | 14,872 | No | 4 | S | Direct | |
| American Depositary Shares | Disposition | 2018-03-16 | 2,208 | $156.75 | 12,664 | No | 4 | S | Direct | |
| American Depositary Shares | Disposition | 2018-03-16 | 7,264 | $157.41 | 5,400 | No | 4 | S | Direct | |
| Amerian Depositary Shares | Disposition | 2018-03-16 | 400 | $157.98 | 5,000 | No | 4 | S | Direct | |
| American Depositary Shares | Acquisiton | 2018-03-19 | 24,128 | $6.50 | 29,128 | No | 4 | M | Direct | |
| American Depositary Shares | Disposition | 2018-03-19 | 500 | $158.45 | 28,628 | No | 4 | S | Direct | |
| American Depositary Shares | Disposition | 2018-03-19 | 5,200 | $159.62 | 23,428 | No | 4 | S | Direct | |
| American Depositary Shares | Disposition | 2018-03-19 | 9,618 | $160.60 | 13,810 | No | 4 | S | Direct | |
| American Depositary Shares | Disposition | 2018-03-19 | 3,141 | $161.62 | 10,669 | No | 4 | S | Direct | |
| American Depositary Shares | Disposition | 2018-03-19 | 5,133 | $162.79 | 5,536 | No | 4 | S | Direct | |
| American Depositary Shares | Disposition | 2018-03-19 | 4,636 | $163.48 | 900 | No | 4 | S | Direct | |
| American Depositary Shares | Disposition | 2018-03-19 | 900 | $164.36 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2018-03-16 | 141,336 | $0.00 | 141,336 | $0.50 |
| Ordinary Shares | Share Option (Right to Buy) | Disposition | 2018-03-19 | 313,664 | $0.00 | 313,664 | $0.50 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 4,758,664 | 2025-07-01 | No | 4 | M | Direct | |
| 4,445,000 | 2025-07-01 | No | 4 | M | Direct |
Footnotes
- Each American Depositary Share ("ADS") represents 13 Ordinary Shares.
- The exercise price is represented in ADSs.
- The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $155.95 to $156.94, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of ADSs sold at each separate price.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.95 to $157.93, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of ADSs sold at each separate price.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $157.97 to $157.98, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of ADSs sold at each separate price.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $158.04 to $158.86, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of ADSs sold at each separate price.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $159.06 to $160.05, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of ADSs sold at each separate price.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $160.07 to $161.05, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of ADSs sold at each separate price.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $161.13 to $162.05, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of ADSs sold at each separate price.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $162.15 to $163.13, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of ADSs sold at each separate price.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $163.16 to $164.15, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of ADSs sold at each separate price.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $164.16 to $165.03, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of ADSs sold at each separate price.
- The number of securities underlying each option and the exercise price therefor are represented in ordinary shares.
- These securities vest over a four-year period as follows: 25% on July 15, 2016, and the remaining in 36 successive equal monthly installments, subject to continued service. All unvested shares subject to this option are subject to accelerated vesting upon a sale event or certain termination events.
Billionaire Hedge Funds
